CHEMOMAB THERAPEUTICS LTD (CMMB) Stock Balance Sheet
NASDAQ:CMMB - Nasdaq - US16385C1045 - ADR - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 8.34M | 6.07M | 9.29M | 13.52M | 15.19M | |||
| Marketable Securities | 2.23M | 8.20M | 10.49M | 26.37M | 45.98M | |||
| Other Current Assets | 1.41M | 1.77M | 1.11M | 1.85M | 1.53M | |||
| Total Current Assets | 11.98M | 16.04M | 20.90M | 41.74M | 62.69M | |||
| Non-Current Assets | ||||||||
| PPE Net | 501.00K | 539.00K | 695.00K | 590.00K | 700.00K | |||
| Other Non-Current Assets | 341.00K | 385.00K | 559.00K | 730.00K | 960.00K | |||
| Total Non-Current Assets | 842.00K | 924.00K | 1.25M | 1.32M | 1.66M | |||
| TOTAL ASSETS | 12.82M | 16.96M | 22.15M | 43.06M | 64.35M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 1.76M | 2.55M | 4.32M | 5.06M | 1.31M | |||
| Accounts Payable | 490.00K | 666.00K | 516.00K | 1.69M | 1.34M | |||
| Total Current Liabilities | 2.25M | 3.22M | 4.84M | 6.75M | 2.65M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 179.00K | 209.00K | 316.00K | 90.00K | 240.00K | |||
| Total Non-Current Liabilities | 179.00K | 209.00K | 316.00K | 90.00K | 240.00K | |||
| TOTAL LIABILITIES | 2.43M | 3.43M | 5.15M | 6.84M | 2.89M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -105.95M | -102.62M | -88.68M | -63.82M | -36.17M | |||
| Additional Paid In Capital | 116.34M | 116.16M | 105.67M | 101.26M | 97.64M | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | N/A | N/A | 0.00 | -1.22M | N/A | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 15.60M | 15.59M | 587.20K | 601.06K | 589.49K | |||
| Tangible Book Value per Share | 0.03 | 0.04 | 1.20 | 2.49 | 4.31 | |||
| Total Shareholders' Equity | 10.39M | 13.54M | 17.00M | 36.22M | 61.47M | |||
| TOTAL LIABILITIES AND EQUITY | 12.82M | 16.96M | 22.15M | 43.06M | 64.35M | |||
| Statistics | ||||||||
| Current Ratio | 5.33 | 4.98 | 4.32 | 6.18 | 23.66 | |||
| Return On Assets (ROA) | -104.53% | -82.20% | -109.34% | -64.21% | -19.39% | |||
| Return On Equity (ROE) | -128.93% | -103.01% | -142.50% | -76.34% | -20.30% | |||
All data in USD , ROIC based on taxRate of 0.21